E. Zhang

Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression—risks, screening, diagnosis and management

D. Rubin, P. Gibson, B. Christensen, 2022, Alimentary pharmacology & therapeutics.

Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis

C. Kiely, S. Tattersall, E. Zhang, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment‐free and overall survival in Chronic Lymphocytic Leukaemia

O. G. Best, S. Mulligan, W. Stevenson, 2018, British journal of haematology.

The Effects of the COVID Pandemic on Patients with IBD: Lessons Learned and Future Directions

F. Macrae, B. Christensen, E. Zhang, 2022, Journal of clinical medicine.

Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments

Thi H. O. Nguyen, L. Rowntree, B. Christensen, 2022, medRxiv.

SARS‐CoV‐2 vaccination in patients with inflammatory bowel disease

S. Connor, R. Bryant, B. Christensen, 2021, GastroHep.

Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease

F. Macrae, B. Christensen, R. Leong, 2022, Canadian journal of gastroenterology & hepatology.

Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities

M. Davenport, K. Subbarao, J. Crawford, 2023, Nature Immunology.